• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁死亡在癌症和癌症免疫治疗中的作用。

Ferroptosis in cancer and cancer immunotherapy.

机构信息

Epartment of urology surgery, Zhejiang hospital, Zhejiang University School of Medicine, Hangzhou, China.

School of MOE Key Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, Zhejiang, 310058, China.

出版信息

Cancer Commun (Lond). 2022 Feb;42(2):88-116. doi: 10.1002/cac2.12250.

DOI:10.1002/cac2.12250
PMID:35133083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8822596/
Abstract

The hallmark of tumorigenesis is the successful circumvention of cell death regulation for achieving unlimited replication and immortality. Ferroptosis is a newly identified type of cell death dependent on lipid peroxidation which differs from classical programmed cell death in terms of morphology, physiology and biochemistry. The broad spectrum of injury and tumor tolerance are the main reasons for radiotherapy and chemotherapy failure. The effective rate of tumor immunotherapy as a new treatment method is less than 30%. Ferroptosis can be seen in radiotherapy, chemotherapy, and tumor immunotherapy; therefore, ferroptosis activation may be a potential strategy to overcome the drug resistance mechanism of traditional cancer treatments. In this review, the characteristics and causes of cell death by lipid peroxidation in ferroptosis are briefly described. In addition, the three metabolic regulations of ferroptosis and its crosstalk with classical signaling pathways are summarized. Collectively, these findings suggest the vital role of ferroptosis in immunotherapy based on the interaction of ferroptosis with tumor immunotherapy, chemotherapy and radiotherapy, thus, indicating the remarkable potential of ferroptosis in cancer treatment.

摘要

肿瘤发生的标志是成功规避细胞死亡调控,以实现无限复制和永生。铁死亡是一种新发现的依赖于脂质过氧化的细胞死亡类型,其在形态、生理学和生物化学方面与经典的程序性细胞死亡不同。广泛的损伤和肿瘤耐受是放疗和化疗失败的主要原因。肿瘤免疫治疗作为一种新的治疗方法的有效率低于 30%。铁死亡可发生于放疗、化疗和肿瘤免疫治疗中;因此,铁死亡的激活可能是克服传统癌症治疗药物耐药机制的一种潜在策略。在这篇综述中,简要描述了铁死亡中脂质过氧化引起的细胞死亡的特征和原因。此外,还总结了铁死亡的三种代谢调控及其与经典信号通路的串扰。总的来说,这些发现表明铁死亡在基于铁死亡与肿瘤免疫治疗、化疗和放疗相互作用的免疫治疗中起着重要作用,从而表明铁死亡在癌症治疗中有显著的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a17c/8822596/745fe45bcaeb/CAC2-42-88-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a17c/8822596/7047f750ba1c/CAC2-42-88-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a17c/8822596/62f25ed5c0b0/CAC2-42-88-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a17c/8822596/8b3a9eedd5d6/CAC2-42-88-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a17c/8822596/d03683633083/CAC2-42-88-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a17c/8822596/745fe45bcaeb/CAC2-42-88-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a17c/8822596/7047f750ba1c/CAC2-42-88-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a17c/8822596/62f25ed5c0b0/CAC2-42-88-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a17c/8822596/8b3a9eedd5d6/CAC2-42-88-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a17c/8822596/d03683633083/CAC2-42-88-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a17c/8822596/745fe45bcaeb/CAC2-42-88-g004.jpg

相似文献

1
Ferroptosis in cancer and cancer immunotherapy.铁死亡在癌症和癌症免疫治疗中的作用。
Cancer Commun (Lond). 2022 Feb;42(2):88-116. doi: 10.1002/cac2.12250.
2
Ferroptosis: A New Promising Target for Lung Cancer Therapy.铁死亡:肺癌治疗的新靶点。
Oxid Med Cell Longev. 2021 Sep 25;2021:8457521. doi: 10.1155/2021/8457521. eCollection 2021.
3
The mechanisms and therapeutic targets of ferroptosis in cancer.铁死亡在癌症中的机制和治疗靶点。
Expert Opin Ther Targets. 2021 Nov;25(11):965-986. doi: 10.1080/14728222.2021.2011206. Epub 2021 Dec 30.
4
Ferroptosis is an effective strategy for cancer therapy.铁死亡是一种有效的癌症治疗策略。
Med Oncol. 2024 Apr 23;41(5):124. doi: 10.1007/s12032-024-02317-5.
5
Targeting the Macrophage-Ferroptosis Crosstalk: A Novel Insight into Tumor Immunotherapy.靶向巨噬细胞-铁死亡串扰:肿瘤免疫治疗的新见解。
Front Biosci (Landmark Ed). 2022 Jun 27;27(7):203. doi: 10.31083/j.fbl2707203.
6
Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy.纳米医学介导的铁死亡靶向策略用于协同癌症治疗。
J Mater Chem B. 2023 Feb 8;11(6):1171-1190. doi: 10.1039/d2tb02161g.
7
Ferroptosis, radiotherapy, and combination therapeutic strategies.铁死亡、放疗及联合治疗策略。
Protein Cell. 2021 Nov;12(11):836-857. doi: 10.1007/s13238-021-00841-y. Epub 2021 Apr 23.
8
CAMKK2 Defines Ferroptosis Sensitivity of Melanoma Cells by Regulating AMPK‒NRF2 Pathway.CAMKK2 通过调控 AMPK‒NRF2 通路定义黑色素瘤细胞的铁死亡敏感性。
J Invest Dermatol. 2022 Jan;142(1):189-200.e8. doi: 10.1016/j.jid.2021.05.025. Epub 2021 Jul 7.
9
Targeting ferroptosis in pancreatic cancer: a double-edged sword.靶向胰腺癌中的铁死亡:一把双刃剑。
Trends Cancer. 2021 Oct;7(10):891-901. doi: 10.1016/j.trecan.2021.04.005. Epub 2021 May 20.
10
Ferroptosis in cancer therapy: a novel approach to reversing drug resistance.铁死亡在癌症治疗中的作用:逆转耐药性的新策略
Mol Cancer. 2022 Feb 12;21(1):47. doi: 10.1186/s12943-022-01530-y.

引用本文的文献

1
Increased CAPG inhibits ferroptosis to drive tumor proliferation and sorafenib resistance in hepatocellular carcinoma via the WDR74-p53-SLC7A11 pathway.CAPG表达增加通过WDR74-p53-SLC7A11途径抑制铁死亡,从而促进肝癌细胞增殖并导致索拉非尼耐药。
Int J Biol Sci. 2025 Aug 22;21(12):5476-5495. doi: 10.7150/ijbs.111419. eCollection 2025.
2
The protective effect and mechanism of dexmedetomidine in inhibiting ferroptosis.右美托咪定在抑制铁死亡中的保护作用及机制
Front Pharmacol. 2025 Aug 29;16:1605363. doi: 10.3389/fphar.2025.1605363. eCollection 2025.
3
Natural Agents Modulating Ferroptosis in Cancer: Molecular Pathways and Therapeutic Perspectives.

本文引用的文献

1
GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis.GOT1 抑制通过铁死亡促进胰腺癌细胞死亡。
Nat Commun. 2021 Aug 11;12(1):4860. doi: 10.1038/s41467-021-24859-2.
2
A Ferrocene-Functionalized Covalent Organic Framework for Enhancing Chemodynamic Therapy via Redox Dyshomeostasis.基于电对失衡的铁基金属有机框架用于提升化学动力学治疗效果
Small. 2021 Aug;17(32):e2101368. doi: 10.1002/smll.202101368. Epub 2021 Jul 3.
3
Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer.
调节癌症中铁死亡的天然因子:分子途径与治疗前景
J Cell Mol Med. 2025 Sep;29(17):e70834. doi: 10.1111/jcmm.70834.
4
Ferroptosis and head and neck cancer: Mechanisms and therapeutic perspectives (Review).铁死亡与头颈癌:机制与治疗前景(综述)
Int J Mol Med. 2025 Nov;56(5). doi: 10.3892/ijmm.2025.5625. Epub 2025 Sep 5.
5
Programmed Cell Death in Cancer.癌症中的程序性细胞死亡
MedComm (2020). 2025 Aug 31;6(9):e70357. doi: 10.1002/mco2.70357. eCollection 2025 Sep.
6
Cooperative targeting of NF-κB enhances ferroptosis-driven HCC therapy with Alisertib and Donafenib.对核因子κB的协同靶向增强了阿利西替尼和多纳非尼对铁死亡驱动的肝癌治疗效果。
Front Cell Dev Biol. 2025 Aug 13;13:1637767. doi: 10.3389/fcell.2025.1637767. eCollection 2025.
7
New Approaches and Strategies for the Repurposing of Iron Chelating/Antioxidant Drugs for Diseases of Free Radical Pathology in Medicine.铁螯合/抗氧化药物在医学中用于自由基病理疾病的重新利用的新方法和策略。
Antioxidants (Basel). 2025 Aug 10;14(8):982. doi: 10.3390/antiox14080982.
8
Emerging dual role of ferroptosis in lung cancer (Review).铁死亡在肺癌中的新兴双重作用(综述)
Oncol Rep. 2025 Nov;54(5). doi: 10.3892/or.2025.8974. Epub 2025 Aug 24.
9
Ferroptosis induction by engineered liposomes for enhanced tumor therapy.工程化脂质体诱导铁死亡用于增强肿瘤治疗
Beilstein J Nanotechnol. 2025 Aug 14;16:1325-1349. doi: 10.3762/bjnano.16.97. eCollection 2025.
10
The Role of Ferroptosis in Women's Health and Diseases.铁死亡在女性健康与疾病中的作用
MedComm (2020). 2025 Aug 15;6(8):e70296. doi: 10.1002/mco2.70296. eCollection 2025 Aug.
酸度激活的动态纳米颗粒增强铁死亡以用于癌症的免疫治疗。
Adv Mater. 2021 Aug;33(31):e2101155. doi: 10.1002/adma.202101155. Epub 2021 Jun 25.
4
Advancing to the era of cancer immunotherapy.迈入癌症免疫治疗时代。
Cancer Commun (Lond). 2021 Sep;41(9):803-829. doi: 10.1002/cac2.12178. Epub 2021 Jun 24.
5
A mitochondrial gatekeeper that helps cells escape death by ferroptosis.一种帮助细胞逃避铁死亡的线粒体守门蛋白。
Nature. 2021 May;593(7860):514-515. doi: 10.1038/d41586-021-01203-8.
6
DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer.DHODH 介导的铁死亡防御是癌症的一个可靶向弱点。
Nature. 2021 May;593(7860):586-590. doi: 10.1038/s41586-021-03539-7. Epub 2021 May 12.
7
Ferroptosis in infection, inflammation, and immunity.铁死亡在感染、炎症和免疫中的作用。
J Exp Med. 2021 Jun 7;218(6). doi: 10.1084/jem.20210518. Epub 2021 May 12.
8
Cancer-Cell-Activated in situ Synthesis of Mitochondria-Targeting AIE Photosensitizer for Precise Photodynamic Therapy.癌细胞激活原位合成的线粒体靶向 AIE 光敏剂用于精准光动力治疗。
Angew Chem Int Ed Engl. 2021 Jun 25;60(27):14945-14953. doi: 10.1002/anie.202017350. Epub 2021 May 31.
9
Emerging mechanisms and targeted therapy of ferroptosis in cancer.铁死亡在癌症中的新兴机制和靶向治疗。
Mol Ther. 2021 Jul 7;29(7):2185-2208. doi: 10.1016/j.ymthe.2021.03.022. Epub 2021 Mar 29.
10
Fe(II) and Tannic Acid-Cloaked MOF as Carrier of Artemisinin for Supply of Ferrous Ions to Enhance Treatment of Triple-Negative Breast Cancer.亚铁离子和单宁酸包覆的金属有机框架作为青蒿素载体用于提供亚铁离子以增强三阴性乳腺癌的治疗
Nanoscale Res Lett. 2021 Feb 23;16(1):37. doi: 10.1186/s11671-021-03497-z.